Sarepta Therapeutics

+$3.40 (+4.73%) Today

$0.00 (0.00%) As of 11:06 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SRPT and other ETFs, options, and stocks.

About SRPT

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

CEO

Douglas S. Ingram

Employees

840

Headquarters

Cambridge, Massachusetts

Founded

1980

SRPT Key Statistics

Market cap

Price-Earnings ratio

—

Dividend yield

—

Average volume

720.58K

High today

$75.46

Low today

$70.50

Open price

$70.55

Volume

1.74M

52 Week high

$101.24

52 Week low

$61.28

SRPT News

CNBCJun 23

Stocks making the biggest moves after hours: FedEx, Sarepta Therapeutics and more - CNBC

Engineers move a 350-volt battery pack to be installed in a Fedex Corp. Express General Motors Co. (GM) van at the VIA Motors Inc. facility in Orem, Utah, U.S.

BenzingaJun 23

Sarepta Therapeutics' Shares Plummet Following FDA's Clinical Hold On MOMENTUM Study

The U.S. Food and Drug Administration (FDA) has placed a clinical hold on SRP-5051 (vesleteplirsen), Sarepta Therapeutics' SRPT lead candidate to treat patients

Simply Wall StJun 20

Insiders may be rethinking their US$2.3m Sarepta Therapeutics, Inc. investment now that the company has lost US$191m in value - Simply Wall St

Insiders who bought US$2.3m worth of Sarepta Therapeutics, Inc.'s ( ) stock at an average buy price of US$79.86 over the last year may be disappointed by the re

Analyst ratings

Buy

76.2%

Hold

23.8%

Sell

SRPT Earnings

-$1.89

-$1.26

-$0.63

$0.00

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Estimated

— per share

Actual

Expected Aug 3, After Hours

Why Robinhood?

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA. View more

Stocks making the biggest moves after hours: FedEx, Sarepta Therapeutics and more - CNBC

Sarepta Therapeutics' Shares Plummet Following FDA's Clinical Hold On MOMENTUM Study

Insiders may be rethinking their US$2.3m Sarepta Therapeutics, Inc. investment now that the company has lost US$191m in value - Simply Wall St

76%

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.